Refeeding syndrome (RFS) is a well-described state of the series of metabolic and biochemical changes that can occur during the feeding of malnourished persons. The shifts in fluids and electrolytes can lead to complications during artificial feeding, which if not recognised and untreated can lead to death. Although the physiology and pathophysiology of RFS is well known, the circumstances under which the RFS appears, clinical manifestations and management of these patients are less clear. There are few published studies describing the occurrence of RFS in children. We describe two cases of RFS in children. The first case is a boy with unrecognised coeliac disease and second case is a girl with cerebral palsy. In both cases, the RFS has developed without clinical symptoms and it was shown only through laboratory findings. Electrolyte disturbances have been successfully corrected and treatment of the underlying disease continued.
INTRODUCTION
Refeeding syndrome (RFS) describes the biochemical changes, clinical manifestations and complications that can occur as a consequence of feeding a malnourished catabolic individual. 1 It is defined as severe (and potentially fatal), electrolyte and fluid shifts associated with metabolic abnormalities in malnourished patients undergoing refeeding, whether orally, enterally or parenterally. The hallmark findings are fluid and electrolyte dysregulation, including hypophosphataemia, hypomagnesaemia, hypokalemia, abnormalities in glucose metabolism, vitamin (importantly thiamine) and trace element deficiencies. 2, 3 During realimentation, insulin stimulates the entry of glucose, phosphorus, magnesium and potassium into the cells. All these minerals and cofactors (as thiamine) are needed for rapid glycogen, protein and fat synthesis in refeeding. Symptoms of RFS are variable, unpredictable and reflect the type and severity of underlined biochemical abnormality. The spectrum of presentation may range from nausea, vomiting to respiratory insufficiency, cardiac failure, hypotension, arrhythmias, coma and death. 1, 2, 4 Therefore, prevention and early identification of patients at risk, monitoring during refeeding and appropriate feeding regimen are the keys to successful treatment. 1 Refeeding should be started at no more than 50% of energy requirements in patients who have not eaten little or nothing for 45 days. For patients with high risk (chronically undernourished, little or no nutritional intake for 410 days) nutritional repletion should started be even more slowly (max. 0.042 MJ/kg/day (10 kcal/kg/day or even less) and slowly increased to full needs over 4-7 days. 7 Although, most of the published case reports refer to adult patients, there are some recent reports on RFS occurring in children with coeliac and Crohn's disease. 5, 6 We present two pediatric cases of RFS, one in a child with coeliac disease and the other one in child with cerebral palsy.
CASE 1
At admission to our hospital, a boy at the age of 8 years was listless and emaciated with the 6-month history of weight loss, diarrhoea and vomiting. On examination, he had pallor and psoriatic skin lesions on the extremities. Due to metabolic acidosis, dehydration and electrolyte disarrangement, he received intravenous fluids and enteral nutrition with elemental formula that were gradually introduced. Although he improved clinically, after 5 days, he developed hypophosphataemia reflecting development of RFS. At this point, phosphorus was replaced intravenously for 3 days. Gradually, hypophosphataemia got corrected and stayed within the normal range after the desired and adequate oral caloric intake was achieved. Meanwhile, the diagnosis of coeliac disease was confirmed based on positive tissue transglutaminase antibody and total villous atrophy on duodenal biopsy. The flow of treatment and laboratory test results with basic data are shown in Table 1 .
CASE 2
At the admission, a 10-year-old girl with cerebral palsy and haemathemesis was pale, grossly emaciated and undernourished. Immediately after the initial laboratory investigation, she received packed red blood cell transfusion. Additionally in view of prior poor oral intake and diarrhoea, she was given partial parenteral nutrition together with enteral nutrition by nasogastric tube. During the first day of feeding, her serum phosphate, magnesium, calcium and potassium dropped reflecting RFS. Supplements of phosphorous, potassium and magnesium were commenced and the electrolyte concentrations were normalised gradually. Enteral nutrition was progressively increased while parenteral nutrition was decreased and finally stopped after 8 days and the girl continued to gain weight. The flow of treatment and laboratory test results with basic data are shown in Table 2 . Enteral Nutrition (gluten and lactose free for oral and nasogastric tube feeding): Peptamen (Nestlé HealthCare Nutrition, Switzerland) diluted with water in ratio 1:1 or 1:2). E: Intravenous rehydration solution (glucose, potassium and calcium chloride, sodium bicarbonate -separately).
